Suchergebnisse - "Frasca, Francesco"

PubPharm (140)

1

Reappraising the role of thyroid scintigraphy in the era of TIRADS : A clinically-oriented viewpoint

enthalten in: Endocrine | 2024

von Trimboli, P. | Bojunga, J. | Deandrea, M. | +10

2

Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer : A Single-Center Retrospective Study

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2024

von Prinzi, A. | Frasca, F. | Russo, M. | +3

3

Digital Technology for Diabetes

enthalten in: The New England journal of medicine | 2024

von Tumminia, A. | Gullo, D. | Frasca, F.

CommentOn: N Engl J Med. 2023 Nov 30;389(22):2076-2086. - PMID 38048189

4

Papillary thyroid carcinoma: ≤ 10 mm does not always mean pN0. A multicentric real-world study

enthalten in: Updates in surgery | 2024

von Amendola, S. | Piticchio, T. | Scappaticcio, L. | +13

5

Head-to-head comparison of American, European, and Asian TIRADSs in thyroid nodule assessment : systematic review and meta-analysis

enthalten in: European thyroid journal | 2024

von Piticchio, T. | Russ, G. | Radzina, M. | +3

6

Inflammatory Profile Assessment in a Highly Selected Athyreotic Population Undergoing Controlled and Standardized Hypothyroidism

enthalten in: Biomedicines | 2024

von Piticchio, T. | Savarino, F. | Volpe, S. | +5

7

Determinants of circulating calcitonin value : analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma

enthalten in: Frontiers in oncology | 2024

von Trimboli, P. | Peloni, G. | Confalonieri, D. | +6

8

Prevalence and significance of indeterminate calcitonin values in patients with thyroid nodules : A systematic review and meta-analysis

enthalten in: Reviews in endocrine & metabolic disorders | 2023

von Piticchio, T. | Frasca, F. | Trimboli, P.

9

Cinque anni di trattamento con GH ricombinante a somministrazione settimanale $\mathit{vs}$ quotidiana. Estensione di uno studio di fase 2

enthalten in: L' endocrinologo | 2023

von Volpe, S. | Frasca, F.

10

Cinque anni di trattamento con GH ricombinante a somministrazione settimanale $\mathit{vs}$ quotidiana. Estensione di uno studio di fase 2

enthalten in: L' endocrinologo | 2023

von Volpe, S. | Frasca, F.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]